BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals

  February 10, 2025

   · 

  1 min read
• Press Releases

  Synthetic Biology Market Size Poised to Surge $191.48 Bn in 2034 at 25.04% CAGR by 2034

  February 10, 2025

   · 

  1 min read
• Press Releases

  Alterity Therapeutics Raises A$40.0 million in Placement

  February 10, 2025

   · 

  6 min read
• Press Releases

  Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma

  February 10, 2025

   · 

  18 min read
• Press Releases

  Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025

  February 10, 2025

   · 

  1 min read
• Press Releases

  Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025

  February 10, 2025

   · 

  1 min read
• Press Releases

  BioCryst to Report Fourth Quarter 2024 Financial Results on February 24

  February 10, 2025

   · 

  1 min read
• Press Releases

  Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting

  February 10, 2025

   · 

  9 min read
• Press Releases

  Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

  February 10, 2025

   · 

  8 min read
• Press Releases

  Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation

  February 10, 2025

   · 

  5 min read